Combining all-trans retinoic acid (ATRA) with arsenic trioxide (ATO) and idarubicin significantly improved event-free survival (EFS) compared with the standard treatment of ATRA and ...
All-trans retinoic acid and arsenic trioxide (ATRA-ATO) combination therapy demonstrates superior event-free survival and lower molecular relapse rates compared to standard ATRA plus ...
Purpose A randomized clinical trial compared efficacy and toxicity of standard all- trans -retinoic acid (ATRA) plus chemotherapy versus ATRA plus arsenic trioxide in patients with newly diagnosed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results